Invention Grant
- Patent Title: Composition comprising hyaluronic acid and mepivacaine
-
Application No.: US17003377Application Date: 2020-08-26
-
Publication No.: US11406738B2Publication Date: 2022-08-09
- Inventor: Francois Bourdon , Stephane Meunier
- Applicant: Teoxane
- Applicant Address: CH Geneva
- Assignee: Teoxane
- Current Assignee: Teoxane
- Current Assignee Address: CH Geneva
- Agency: Shumaker, Loop & Kendrick, LLP
- Main IPC: A61L27/54
- IPC: A61L27/54 ; A61K8/49 ; A61K31/167 ; A61K31/451 ; A61K31/728 ; A61K8/73 ; A61Q19/08 ; A61K31/16 ; A61K31/445 ; A61K8/24 ; A61K9/00 ; A61K47/02 ; A61L27/12 ; A61L27/20

Abstract:
Compositions and methods for the surface appearance of the skin a subject are provided. An injectable composition comprising at least hyaluronic acid or a salt thereof; and an effective amount of at least mepivacaine or a salt thereof are provided. The hyaluronic acid optionally has an average molecular weight ranging from 50,000 to 10,000,000 Daltons, and may be crosslinked hyaluronic acids, non-crosslinked hyaluronic acids, or a combination, in some embodiments. The compositions and methods of the present invention are useful for treating and preventing the cutaneous signs of chronological aging and/or induced by external factors such as stress, air pollution, tobacco or prolonged exposure to ultraviolet (UV) exposure, impaired surface appearance of the skin, impaired viscoelastic or biomechanical properties of the skin, and/or the long-lasting filling of volume defects of the skin.
Information query